American Society of Clinical Oncology

SHERPA: White

People

  1. Horwitz
    Horwitz
  2. Palomba
    Palomba
  3. Moskowitz
    Moskowitz
  4. Zelenetz
    Zelenetz
  5. Dogan
    Dogan
  6. Hamlin
    Hamlin
  7. Kumar
    Kumar
  8. Noy
    Noy
  9. Schoder
    Schoder
  10. Vardhana
    Vardhana

Groups

  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies, Division of (14)
  4. Lymphoma (14)
  5. Sloan Kettering Institute Postdocs (14)
  6. Executive Committee, Center for Hematologic Malignancies (8)
  7. GSK Faculty (7)
  8. Population Sciences Research Program (7)
  9. Epidemiology and Biostatistics (6)
  10. Survivorship Research (6)
Search Within
  1. "Lymphoma"
  2. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (3)
Groups
  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies, Division of (14)
  4. Lymphoma (14)
  5. Sloan Kettering Institute Postdocs (14)
  6. Executive Committee, Center for Hematologic Malignancies (8)

More Groups

People
  1. Anas Younes (6)
  2. Erel Joffe (6)
  3. Maria Palomba (6)
  4. Steven Horwitz (6)
  5. Ahmet Dogan (5)
  6. Alison Moskowitz (5)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (5)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unique microbial profile identified in patients with gastric cancer with pathologic response to neoadjuvant chemotherapy
    Meeting Abstract

    Drebin, H. M.; Abate, M.; Fei, T.; Tang, L. H.; Laszkowska, M.; Maron, S. B.; Shimada, S.; Vardhana, S.; Vanderbilt, C.; Strong, V. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Symptomatic delayed seromas vs incidental findings on MR, and likelihood of BIA-ALCL in women with textured implants
    Meeting Abstract

    Ghione, P.; Sutton, E. J.; Hu, Q.; Galasso, N.; Ganesan, N.; Tyagi, N.; Martinez, D. F.; Dogan, A.; Morris, E. A.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Carter, J.; Dogan, A.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; Abramson, J. S.; Batlevi, C. L.; Joffe, E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q. Y.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Romidepsin activity in T follicular helper(TFH)-phenotype PTCL versus non TFH treated on the same clinical trials
    Meeting Abstract

    Ghione, P.; Ozkaya, N.; Faruque, P.; Mehta-Shah, N.; Lunning, M. A.; Ruan, J.; Galasso, N.; Moskowitz, A. J.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save